An Overview of Nanoparticle Protein Corona Literature
Small · 2023-09 · 19 (36)
DOI: 10.1002/smll.202301838 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small, online erschienen am 29.04.2023. Verfasst von Mohammad J Hajipour und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Precision Health Program, Michigan State University, East Lansing, MI, 48824, USA. Hauptthemen laut MEDLINE: Protein Corona, Nanoparticles, Metal Nanoparticles. Die Arbeit wurde bisher 149-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
The protein corona forms spontaneously on nanoparticle surfaces when nanomaterials are introduced into any biological system/fluid. Reliable characterization of the protein corona is, therefore, a vital step in the development of safe and efficient diagnostic and therapeutic nanomedicine products. 2134 published manuscripts on the protein corona are reviewed and a down‐selection of 470 papers spanning 2000–2021, comprising 1702 nanoparticle (NP) systems is analyzed. This analysis reveals: i) most corona studies have been conducted on metal and metal oxide nanoparticles; ii) despite their overwhelming presence in clinical practice, lipid‐based NPs are underrepresented in protein corona research, iii) studies use new methods to improve reliability and reproducibility in protein corona research; iv) studies use more specific protein sources toward personalized medicine; and v) careful characterization of nanoparticles after corona formation is imperative to minimize the role of aggregation and protein contamination on corona outcomes. As nanoparticles used in biomedicine become increasingly prevalent and biochemically complex, the field of protein corona research will need to focus on developing analytical approaches and characterization techniques appropriate for each unique nanoparticle formulation. Achieving such characterization of the nano‐bio interface of nanobiotechnologies will enable more seamless development and safe implementation of nanoparticles in medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology and Precision Health Program, Michigan State University, East Lansing, MI, 48824, USA.
- Department of Radiology, Stanford University, Stanford, CA, 94304, USA.
- Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN, 46556, USA.
- Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Airport Rd., 11733, Amman, Jordan.
- Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, 2713, Qatar.
- Department of Chemical and Biomolecular Engineering, University of California, Berkeley, CA, 94720, USA.
ORCID-Profile: Markita P Landry, Morteza Mahmoudi
Förderung
- NIDDK NIH HHS
Zitieren
APA
Hajipour, M. J., Safavi-Sohi, R., Sharifi, S., Mahmoud, N., Ashkarran, A. A., Voke, E., Serpooshan, V., Ramezankhani, M., Milani, A. S., Landry, M. P., & Mahmoudi, M. (2023). An Overview of Nanoparticle Protein Corona Literature. Small, 19(36). https://doi.org/10.1002/smll.202301838
Vancouver
Hajipour MJ, Safavi-Sohi R, Sharifi S, Mahmoud N, Ashkarran AA, Voke E, et al. An Overview of Nanoparticle Protein Corona Literature. Small. 2023;19(36). doi:10.1002/smll.202301838
BibTeX
@article{Hajipour2023,
author = {Hajipour, Mohammad J and Safavi-Sohi, Reihaneh and Sharifi, Shahriar and Mahmoud, Nouf and Ashkarran, Ali Akbar and Voke, Elizabeth and Serpooshan, Vahid and Ramezankhani, Milad and Milani, Abbas S and Landry, Markita P and Mahmoudi, Morteza},
title = {An Overview of Nanoparticle Protein Corona Literature},
journal = {Small},
year = {2023},
volume = {19},
number = {36},
doi = {10.1002/smll.202301838}
}
EUVIMED